New York Genome Center Inc
- Assets
- $83.5m
- Revenue
- $60.8m
- Investments
- $0.0
- Employees
- 226
- Location
- New York, NY
- Founding
- 01/2012
- Data as of
- 12/2020
- EIN
- 80-0631734
Organization Overview
New York Genome Center Inc is located in New York, NY. The organization was established in 2012. According to its NTEE Classification (E22) the organization is classified as: General Hospitals, under the broad grouping of Health Care and related organizations. As of 12/2021, New York Genome Center Inc employed 226 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. New York Genome Center Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2020, New York Genome Center Inc generated $60.8m in total revenue. This represents a relatively dramatic decline in revenue. Over the past 6 years, the organization has seen revenues fall by an average of (4.4%) each year. All expenses for the organization totaled $72.3m during the year ending 12/2020. As we would expect to see with falling revenues, expenses have declined by (0.9%) per year over the past 6 years. You can explore the organizations financials more deeply in the financial statements section below.
Since 2016, New York Genome Center Inc has awarded 54 individual grants totaling $6,688,333. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2020
Describe the Organization's Mission:
Part 3 - Line 1
ADVANCING GENOMIC RESEARCH TO DRIVE NOVEL BIOMEDICAL DISCOVERIES TO IMPROVE HUMAN HEALTH.
Describe the Organization's Program Activity:
Part 3 - Line 4a
RESEARCH AND RESEARCH SEQUENCING: NYGC'S RESEARCH SCIENTISTS AND FACULTY CONDUCT RESEARCH INTO THE GENETIC FACTORS THAT CONTRIBUTE TO HUMAN DISEASE, BOTH IN THEIR OWN PROJECTS AND THROUGH COLLABORATIONS. NYGC RESEARCHERS HAVE PROJECTS UNDERWAY IN CANCER, INCLUDING LUNG, LIVER, BREAST AND MELANOMA, A MULTISITE VERY RARE CANCER PROJECT AND A LARGE COLLABORATIVE PROJECT STUDYING CANCER IN UNDERSERVED POPULATIONS IN NYC; NEURODEGENERATIVE DISEASES, INCLUDING ALS AND DEMENTIA AND NEUROPSYCHIATRIC DISEASES, FOCUSING ON AUTISM, AMONG OTHERS. IN 2021, NYGC SEQUENCED OVER 4,500 WHOLE GENOME SAMPLES, AS WELL AS NEARLY 6,000 COVID VIRAL SAMPLES, COMPLETED 611 PROJECTS, AND COLLABORATED WITH 101 INVESTIGATORS FROM 52 INSTITUTIONS WORLDWIDE. FOR MORE INFORMATION SEE SCHEDULE O.
CLINICAL SEQUENCING: NYGC IS AUTHORIZED BY THE NEW YORK STATE DEPARTMENT OF HEALTH TO OFFER THE FOLLOWING APPROVED CLINICAL TESTS THROUGH ITS CLEP/CLIA CERTIFIED CLINICAL LABORATORY: CONSTITUTIONAL WHOLE GENOME SEQUENCING FOR UNDIAGNOSED DISEASE, CONSTITUTIONAL WHOLEGENOME SEQUENCING FOR PREDISPOSITIONAL GENETIC SCREENING, ONCOLOGY WHOLE GENOME AND TRANSCRIPTOME SEQUENCING, CONSTITUTIONAL WHOLE EXOME SEQUENCING, TARGETED VARIANT TESTING USING SANGER SEQUENCING, ONCOLOGY WHOLE EXOME AND TRANSCRIPTOME SEQUENCING, AND THE SMASH GENOMIC ASSAY.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Cheryl A Moore President & COO (through 3/21) | OfficerTrustee | 40 | $628,607 |
Tom Maniatis PHD Scientific Director & CEO | OfficerTrustee | 40 | $616,411 |
Elizabeth Brooks O'brien VP & General Counsel | Officer | 40 | $440,292 |
Soren Germer Svp, Genome Technologies | Officer | 40 | $410,837 |
Carol Ashe Chief Business Officer | Officer | 40 | $405,036 |
Thomas Lehner Sci Dir, Neuro Dis Gen | Officer | 40 | $362,827 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Donnelly Mechanical Engineering Services | 12/30/21 | $720,835 |
Guardian Services Industries Inc Cleaning Services | 12/30/21 | $353,833 |
Tec Systems Inc Maintenance Services | 12/30/21 | $177,232 |
Howson & Howson Llp Legal Services | 12/30/21 | $134,310 |
Kpmg Llp Accounting Services | 12/30/21 | $130,113 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Total Revenue from Contributions, Gifts, Grants & Similar | $51,639,109 |
| Investment income | $90,496 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $878,878 |
| Net Rental Income | -$1,064,235 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $60,783,989 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $28,506 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $6,629,835 |
| Compensation to disqualified persons | $112,969 |
| Other salaries and wages | $17,631,050 |
| Pension plan accruals and contributions | $1,156,157 |
| Other employee benefits | $1,247,693 |
| Payroll taxes | $1,951,181 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $312,871 |
| Fees for services: Accounting | $144,638 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $2,325 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $2,842,691 |
| Advertising and promotion | $0 |
| Office expenses | $302,467 |
| Information technology | $2,454,834 |
| Royalties | $268,140 |
| Occupancy | $13,746,760 |
| Travel | $83,962 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $34,967 |
| Interest | $461,726 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $7,805,926 |
| Insurance | $391,158 |
| All other expenses | $0 |
| Total functional expenses | $72,306,280 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $9,393,791 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $4,575,195 |
| Accounts receivable, net | $4,431,588 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $1,246,622 |
| Prepaid expenses and deferred charges | $3,918,628 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $8,714,187 |
| Total assets | $83,547,232 |
| Accounts payable and accrued expenses | $6,075,510 |
| Grants payable | $0 |
| Deferred revenue | $11,521,530 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $71,442 |
| Unsecured mortgages and notes payable | $4,820,000 |
| Other liabilities | $25,106,784 |
| Total liabilities | $47,595,266 |
| Net assets without donor restrictions | $0 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Total liabilities and net assets/fund balances | $35,951,966 |
Grants Awarded
Over the last fiscal year, New York Genome Center Inc has awarded $1,343,279 in support to 12 organizations.
| Grant Recipient | Amount |
|---|---|
New York, NY PURPOSE: RESEARCH SUBAWARD | $440,678 |
Cold Spring Harbor, NY PURPOSE: RESEARCH SUBAWARD | $322,523 |
New York, NY PURPOSE: RESEARCH SUBAWARD | $227,755 |
New York, NY PURPOSE: RESEARCH SUBAWARD | $110,207 |
Cambridge, MA PURPOSE: RESEARCH SUBAWARD | $71,543 |
New York, NY PURPOSE: RESEARCH SUBAWARD | $51,589 |
Grants Recieved
Over the last fiscal year, we have identified 17 grants that New York Genome Center Inc has recieved totaling $26,484,188.
| Awarding Organization | Amount |
|---|---|
Simons Foundation Inc New York, NY PURPOSE: NEW YORK GENOME CENTER 2018 "NEW GIFT" | $20,000,000 |
The Tow Foundation Inc New Canaan, CT PURPOSE: RESTRICTED FUNDING - NEW SEQUENCING TECHNOLOGY EQUIPMENT | $1,500,000 |
Edelman Fam Foundation New York, NY PURPOSE: TO PROVIDE GENERAL SUPPORT TO THE NEW YORK GENOME CENTER TO HOST PUBLIC LECTURES BY RENOWNED SCIENTISTS, CLINICIANS, AND RESEARCHERS. | $1,000,000 |
American Heart Association Inc Dallas, TX PURPOSE: RESEARCH | $805,408 |
Amyotrophic Lateral Sclerosis Assn Arlington, VA PURPOSE: STRATEGTIC INITIATIVE | $575,000 |
The Jpb Foundation New York, NY PURPOSE: THE PROPOSED VIRAL SURVEILLANCE PROGRAM | $500,000 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Northwestern Medical Center Inc St Albans, VT | $180,177,619 | $138,585,936 |
Lehigh Valley Hospital - Schuykill Allentown, PA | $123,931,422 | $141,448,853 |
Beth Israel Deaconess Hospital - Needham Inc Needham, MA | $170,627,277 | $126,877,037 |
Mount St Marys Hospital Of Niagara Falls Buffalo, NY | $85,822,879 | $119,030,413 |
Windham Community Memorial Hospital Inc Willimantic, CT | $68,084,533 | $121,054,683 |
St Lukes Quakertown Hospital Allentown, PA | $224,667,230 | $112,978,373 |
Claxton-Hepburn Medical Center Odensburg, NY | $148,754,209 | $110,908,691 |
Geneva General Hospital Geneva, NY | $241,263,281 | $108,269,094 |
Upmc Pittsburgh, PA | $122,342,039 | $105,892,952 |
Day Kimball Healthcare Inc Putnam, CT | $92,107,218 | $109,975,454 |
Northeastern Pennsylvania Health Corporation Allentown, PA | $304,803,492 | $145,234,138 |
Nathan Littauer Hospital Association Gloversville, NY | $137,432,154 | $112,130,166 |